| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EXTENSIVE CLINICAL EXPERIENCE |
Departments of Endocrinology (A.M.I., G.A.K., C.P., V.F., P.J.J., J.P.M., A.B.G., G.M.B.) and Academic Radiology (R.H.R.), St. Bartholomews Hospital, London EC1A 7BE, United Kingdom; and Department of Endocrinology (J.N.-P.), Division of Clinical Sciences, University of Sheffield, Sheffield S5 7AU, United Kingdom
Address all correspondence and requests for reprints to: Professor A. B. Grossman, Department of Endocrinology, St. Bartholomews Hospital, London EC1A 7BE, United Kingdom. E-mail: a.b.grossman{at}qmul.ac.uk.
Context: There are few large series of patients with ectopic, nonpituitary, corticotropin (ACTH) secretion (EAS).
Objective: The objective of this study was to analyze the clinical, biochemical, and radiological features, management, and treatment outcome of patients with EAS.
Design: This was a retrospective case-record study.
Setting: The setting for this study was a tertiary referral hospital center.
Patients: Forty patients with EAS were studied.
Main Outcome Measures: Clinical, biochemical, and radiological features and response to therapy and survival were measured.
Results: The median follow-up was 5 yr (range, 230 yr). None of the dynamic tests achieved 100% accuracy, but bilateral inferior petrosal sinus sampling showed an absent central gradient in all but one case (one of 12). Imaging correctly identified the lesion at first investigation in 65% of cases. Bronchial carcinoid tumors were the most common cause of EAS (n = 12; 30%), followed by other neuroendocrine tumors (n = 13, 32.5%). In 12.5% of patients, the source of EAS was never found. Octreotide scintigraphy and whole-body venous sampling were of limited value. Surgical attempt at curative resection was successful in 83% (10 of 12) of patients with bronchial carcinoid tumors; others responded generally well to adrenolytic therapy or bilateral adrenalectomy. Tumor histology and the presence of distant metastases were the main predictors of overall survival (P < 0.05).
Conclusions: A variety of tests and imaging studies are necessary for the correct diagnosis of the EAS, but even then, up to 20% of cases present a covert or occult EAS syndrome. These cases require a prolonged follow-up, review, and repetition of diagnostic tests and scans.
This article has been cited by other articles:
![]() |
B. M. K. Biller, A. B. Grossman, P. M. Stewart, S. Melmed, X. Bertagna, J. Bertherat, M. Buchfelder, A. Colao, A. R. Hermus, L. J. Hofland, et al. Treatment of Adrenocorticotropin-Dependent Cushing's Syndrome: A Consensus Statement J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2454 - 2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A Cassier, S. Abou-Amara-Olivieri, P. Artru, M.-G. Lapalus, J.-P. Riou, and C. Lombard-Bohas Mifepristone for ectopic ACTH secretion in metastatic endocrine carcinomas: report of two cases. Eur. J. Endocrinol., June 1, 2008; 158(6): 935 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
J R Meinardi, B H R Wolffenbuttel, and R P F Dullaart Cyclic Cushing's syndrome: a clinical challenge Eur. J. Endocrinol., September 1, 2007; 157(3): 245 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Salgado, M. C. B V. Fragoso, M. Knoepfelmacher, M. C. Machado, S. Domenice, M. A. A. Pereira, and B. B. de Mendonca Ectopic ACTH syndrome: our experience with 25 cases. Eur. J. Endocrinol., November 1, 2006; 155(5): 725 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Findling and H. Raff Cushing's Syndrome: Important Issues in Diagnosis and Management J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3746 - 3753. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.T. Netea-Maier, W.-A. Nieuwlaat, C.G.J. Sweep, P. Wesseling, L. Massuger, and A.R.M.M. Hermus Virilization due to ovarian androgen hypersecretion in a patient with ectopic adrenocorticotrophic hormone secretion caused by a carcinoid tumour: Case Report Hum. Reprod., October 1, 2006; 21(10): 2601 - 2605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. C C. Neto, M. C. Machado, F. Mesquita, N. R. de Castro Musolino, A. C. Toscanini, G. Ochman, V. A. S Cescato, R. Marino Jr, and M. J. Teixeira Thymus hyperplasia after resolution of hypercortisolism in ACTH-dependent Cushing's syndrome: the importance of thymic vein catheterization. Eur. J. Endocrinol., June 1, 2006; 154(6): 807 - 811. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |